The involvement of cholesterol in sepsis and tolerance to lipopolysaccharide highlighted by the transcriptome analysis of zebrafish (Danio rerio)

Zebrafish

Volumn 11, Issue 5, 2014, Pages 421-433

  Dios, Sonia ^a   Balseiro, Pablo ^a   Costa, Maria M ^a   Romero, Alejandro ^a   Boltaña, Sebastián ^b   Roher, Nerea ^b   Mackenzie, Simon ^b   Figueras, Antonio ^a   Novoa, Beatriz ^a  

^a INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FISH PROTEIN; LIPOPOLYSACCHARIDE; TRANSCRIPTOME;

ANIMAL; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; ZEBRA FISH;

ANIMALS; ESCHERICHIA COLI; FISH PROTEINS; LIPOPOLYSACCHARIDES; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; TRANSCRIPTOME; ZEBRAFISH;

EID: 84907435621     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2014.0995     Document Type: Article

References (107)

1. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
2. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(Suppl 7):S109-S116.
3. Parker LC, Jones EC, Prince LR, Dower SK, Whyte MK, Sabroe I. Endotoxin tolerance induces selective alterations in neutrophil function. J Leukoc Biol 2005;78: 1301-1305.
4. Marshall JC. Inflammation, coagulopathy, and the patho-genesis of multiple organ dysfunction syndrome. Crit Care Med 2001;29:S99-S106.
5. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L.Real-time visualization ofmycobacterium-macrophage interactions leading to initiation of granu-loma formation in zebrafish embryos. Immunity 2002;17: 693-702.
6. Lam SH, Chua HL, Gong Z, Lam TJ, Sin YM. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol 2004;28:9-28.
7. Redd MJ, Kelly G, Dunn G, Way M, Martin P. Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil Cytoskeleton 2006;63:415-422.
8. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007;8:353-367.
9. Trede NS, Ota T, Kawasaki H, Paw BH, Katz T, Demarest B, et al. Zebrafish mutants with disrupted early T-cell and thymus development identified in early pressure screen. Dev Dyn 2008;237:2575-2584.
10. Stockhammer OW, Zakrzewska A, Hegedûs Z, Spaink HP, Meijer AH. Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J Immunol 2009;182: 5641-5653.
11. Westerfield M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). Eugene: University of Oregon Press, 2000.
12. Nusslein-Volhard C, Dahm R. Zebrafish, a Practical Approach. Oxford: Oxford University Press, 2002.
13. Novoa B, Bowman TV, Zon L, Figueras A. LPS response and tolerance in the zebrafish (Danio rerio). Fish Shellfish Immunol 2009;26:326-331.
14. Abràmoff MD, Magalhaes PJ, Ram SJ. Image processing with ImageJ. Biophoton Int 2004;11:36-42.
15. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-371.
16. Oliveros JC. VENNY. An interactive tool for comparing lists with Venn Diagrams. 2007. Available at http://bioinfogp.cnb.csic.es/tools/venny/index.html
17. Conesa A, Gotz S, Garcia-Gomez JM, Terol J, Talon M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 2005;21:3674-3676.
18. Alexeyenko A, Wassenberg DM, Lobenhofer EK, Yen J, Linney E, Sonnhammer EL, et al. Dynamic zebrafish interactome reveals transcriptional mechanisms of dioxin toxicity. PLoS One 2010;5:e10465.
19. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, et al. GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics (Oxford, England) 2010;26:2927-2928.
20. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011;27:431-432.
21. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics (Oxford, England) 2005;21:3448-3449.
22. Morris JH, Apeltsin L, Newman AM, Baumbach J, Wittkop T, Su G, et al. ClusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics 2011;12:436.
23. Barsky A, Gardy JL, Hancock RE, Munzner T. Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 2007;23:1040-1042.
24. Rozen S, Skaletsky H. Primer3 on the www for general users and for biologist programmers. Methods Mol Biol 2000;132:365-386.
25. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
26. Willett CE, Cortes A, Zuasti A, Zapata AG. Early he-matopoiesis and developing lymphoid organs in the zeb-rafish. Dev Dyn 1999;214:323-336.
27. Trede NS, Zapata A, Zon LI. Fishing for lymphoid genes. Trends Immunol 2001;22:302-307.
28. Hasselgren PO, Menconi MJ, Fareed MU, Yang H, Wei W, Evenson A. Novel aspects on the regulation of muscle wasting in sepsis. Int J Biochem Cell Biol 2005;37:2156-2168.
29. Hung CC, Liu X, Kwon MY, Kang YH, Chung SW, Perrella MA. Regulation of heme oxygenase-1 gene by peptidoglycan involves the interaction of Elk-1 and C/EBPalpha to increase expression. Am J Physiol Lung Cell Mol Physiol 2010;298:L870-L879.
30. Hua F, Wang J, Ishrat T, Wei W, Atif F, Sayeed I, et al. Genomic profile of Toll-like receptor pathways in trau-matically brain-injured mice: effect of exogenous progesterone. J Neuroinflamm 2011;8:42.
31. Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 2008;14:1106-1111.
32. Cynis H, Hoffmann T, Friedrich D, Kehlen A, Gans K, Kleinschmidt M, et al. The isoenzyme of glutaminyl cy-clase is an important regulator of monocyte infiltration under inflammatory conditions. EMBO Mol Med 2011;3: 545-558.
33. Chen YL, Huang KF, Kuo WC, Lo YC, Lee YM, Wang AH. Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins. Biochem J 2012;442:403-412.
34. Zhang G, Wang J, Kelly J, Gu G, Hou J, Zhou Y, et al. B7-H3 Augments the inflammatory response and is associated with human sepsis. J Immunol 2010;185:3677-3684.
35. Fassbender M, Gerlitzki B, Ullrich N, Lupp C, Klein M, Radsak MP, et al. Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell Immunol 2010;265:91-96.
36. Li S, Miao T, Sebastian M, Bhullar P, Ghaffari E, Liu M, et al. The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells. Immunity 2012;37:685-696.
37. Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) 2010;7:6.
38. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol 2007;179: 647-654.
39. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, et al. The Ashwell receptor mitigates the lethal coa-gulopathy of sepsis. Nat Med 2008;14:648-655.
40. Decker T. Sepsis: avoiding its deadly toll. J Clin Invest 2004;113:1387-1389.
41. Makowski L, Hotamisligil GS. Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004;134:2464S-2468S.
42. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013;93:329-342.
43. Das UN. Is sepsis a pro-resolution deficiency disorder? Med Hypotheses 2013;80:297-299.
44. Li L, Hossain MA, Sadat S, Hager L, Liu L, Tam L, et al. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways. J Biol Chem 2011;286:17809-17820.
45. Bauman DR, Bitmansour AD, McDonald JG, Thompson BM, Liang G, Russell DW. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci USA 2009;106:16764-16769.
46. Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, et al. Marked upregula-tion of cholesterol 25-hydroxylase expression by lipo-polysaccharide. J Lipid Res 2009;50:2258-2264.
47. Park K, Scott AL. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J Leukoc Biol 88;1081-1087.
48. Zou T, Garifulin O, Berland R, Boyartchuk VL. Listeria monocytogenes infection induces pro-survival metabolic signaling in macrophages. Infect Immun 2011;79:1526-1535.
49. Strassheim D, Park JS, Abraham E. Sepsis: current concepts in intracellular signaling. Int J Biochem Cell Biol 2002;34:1527-1533.
50. Haskó G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008;7:759-770.
51. Csóka B, Németh ZH, Rosenberger P, Eltzschig HK, Spolarics Z, Pacher P, et al. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J Immunol 2010;185:542-550.
52. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, et al. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 2010;3:ra55.
53. Aherne CM, Kewley EM, Eltzschig HK. The resurgence of A2B adenosine receptor signaling. Biochim Biophys Acta Biomembr 2011;1808:1329-1339.
54. Ferrero ME. Purinoceptors in inflammation: potential as anti-inflammatory therapeutic targets. Front Biosci 2011;17: 2172-2186.
55. Ramakers BP, Riksen NP, van der Hoeven JG, Smits P, Pickkers P. Modulation of innate immunity by adenosine receptor stimulation. Shock 2011;36:208-215.
56. Dong C, Zhang X, Zhou F, Dou H, Duvernay MT, Zhang P, et al. ADP-ribosylation factors modulate the cell surface transport of G protein-coupled receptors. J Pharmacol Exp Ther 2010;333:174-183.
57. Novoa B, Figueras A. Zebrafish: model for the study of inflammation and the innate immune response to infectious diseases. Adv Exp Med Biol 2012;946:253-275.
58. van der Pouw Kraan TC, Snijders A, Boeije LC, de Groot ER, Alewijnse AE, Leurs R, et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest 1998;102:1866-1873.
59. Caron G, Delneste Y, Roelandts E, Duez C, Herbault N, Magistrelli G, et al. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 2001;166:6000-6006.
60. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001;108:1865-1873.
61. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama M, et al. Histamine inhibits li-popolysaccharide-induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1-and B7.1-dependent manner. J Pharmacol Exp Ther 2003; 304:624-633.
62. Takahashi HK, Iwagaki H, Mori S, Yoshino T, Tanaka N, Nishibori M. Histamine inhibits lipopolysaccharide-induced interleukin (IL)-18 production in human mono-cytes. Clin Immunol 2004;112:30-34.
63. Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009;39:1786-1800.
64. Peng J, Yuan Q, Lin B, Panneerselvam P, Wang X, Luan XL, et al. SARM inhibits both TRIF-and MyD88-mediated AP-1 activation. Eur J Immunol 2010;40:1738-1747.
65. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 2003;284: E671-E678.
66. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in en-dotoxemic rats. Endocrinology 2004;145:4084-4093.
67. Russell JA. Management of sepsis. N Engl J Med 2006; 355:1699-1713.
68. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, et al. Implementation and outcomes of the multiple urgent sepsis therapies (MUST) protocol. Crit Care Med 2006;34:1025-1032.
69. Sato Y, Nishio Y, Sekine O, Kodama K, Nagai Y, Nakamura T, et al. Increased expression of CCAAT/enhancer binding protein-beta and-delta and monocyte chemoattractant protein-1 genes in aortas from hyper-insulinaemic rats. Diabetologia 2007;50:481-489.
70. Authier F, Desbuquois B. Glucagon receptors. Cell Mol Life Sci 2008;65:1880-1899.
71. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin inhibits LPS-induced signaling pathways in alveolar macrophages. Cell Physiol Biochem 2008; 21:297-304.
72. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-kappaB activation in alveolar mac-rophages. Cell Physiol Biochem 2008;22:279-286.
73. Spitzer AL, Harris HW. Statins attenuate sepsis. Surgery 2006;139:283-287.
74. Schuster H. High risk/high priority: familial hypercho-lesterolemia-a paradigm for molecular medicine. Ather-oscler Suppl 2002;2:27-30; discussion 30-32.
75. Tominaga K, Saito S, Matsuura M, Nakano M. Lipopo-lysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-j B cascades, but not lipo-polysaccharide-incorporation steps. Biochim Biophys Acta 1999;1450:130-144.
76. Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000;164:5564-5574.
77. Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002;169:5209-5216.
78. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002;4:903-914.
79. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. Induction of in vitro re-programming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homo-tolerance" versus "heterotolerance" on NF-j B signaling pathway components. J Immunol 2003;170:508-519.
80. Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. Blood 2006;108:3976-3978.
81. Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell En-docrinol 2011;340:44-58.
82. Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 2008;216:83-192.
83. Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, et al. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol 2010;10:118.
84. O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010;116:1136-1146.
85. Shen SS, Callaghan D, Juzwik C, Xiong H, Huang P, Zhang W. ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease. J Neurochem 2010;114:1590-1604.
86. Olson N, Hristova M, Heintz NH, Lounsbury KM, Van Der Vliet A. Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2011;301:L993-L1002.
87. Kao KK, Fink MP. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 2010;80: 151-159.
88. Villafuerte BC, Kaytor EN. An insulin-response element-binding protein that ameliorates hyperglycemia in diabetes. J Biol Chem 2005;280:20010-20020.
89. Villafuerte BC, Barati MT, Song Y, Moore JP, Epstein PN, Portillo J. Transgenic expression of insulin-response element binding protein-1 in beta-cells reproduces type 2 diabetes. Endocrinology 2009;150:2611-2617.
90. Nakamura MT, Nara TY. Gene regulation of mammalian desaturases. Biochem Soc Trans 2002;30:1076-1079.
91. Peake PW, Shen Y, Campbell LV, Charlesworth JA. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun 2006;341:108-115.
92. Benoit ME, Tenner AJ. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci 2011;31:3459-3469.
93. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, et al. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001;159:1199-1209.
94. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-1037.
95. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006;106:63-71.
96. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, Scalea TM. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 2007; 245:611-621.
97. Zhu H, Tang Y, Ivanciu L, Centola M, Lupu C, Taylor FB, Jr., et al. Temporal dynamics of gene expression in the lung in a baboon model of E. coli sepsis. BMC Genomics 2007;8:58.
98. Bhatty M, Fan R, Muir WM, Pruett SB, Nanduri B. Transcriptomic analysis of peritoneal cells in a mouse model of sepsis: confirmatory and novel results in early and late sepsis. BMC Genomics 2012;13:509.
99. Lambeck S, Weber M, Gonnert FA, Mrowka R, Bauer M. Comparison of sepsis-induced transcriptomic changes in a murine model to clinical blood samples identifies common response patterns. Front Microbiol 2012;3:284.
100. Maslove DM, Tang BM, McLean AS. Identification of sepsis subtypes in critically ill adults using gene expression profiling. Crit Care 2012;16:R183.
101. Starr ME, Hu Y, Stromberg AJ, Carmical JR, Wood TG, Evers BM, et al. Gene expression profile of mouse white adipose tissue during inflammatory stress: age-dependent upregulation of major procoagulant factors. Aging Cell 2013;12:194-206.
102. Simons K, Ikonen E. How cells handle cholesterol. Science 2000;290:1721-1726.
103. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
104. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002;110:597-603.
105. Laza-Knoerr AL, Gref R, Couvreur P. Cyclodextrins for drug delivery. J Drug Target 2010;18:645-656.
106. Mura P, Corti G, Cirri M, Maestrelli F, Mennini N, Bragagni M. Development of mucoadhesive films for buccal administration of flufenamic acid: effect of cy-clodextrin complexation. J Pharm Sci 2010;99:3019-3029.
107. Danciu C, Soica C, Csanyi E, Ambrus R, Feflea S, Peev C, et al. Changes in the anti-inflammatory activity of soy isoflavonoid genistein versus genistein incorporated in two types of cyclodextrin derivatives. Chem Cent J 2012;6:58.